2026
-
01
-
26
点击次数:
太美智研医药研发(上海)有限公司(简称“太美智研医药”)，总部位于上海，是AI驱动的医药研发解决方案提供商。依托深厚临床研究积淀，公司深度融合A 技术与创新模式，为全球药械企业及科研机构提供国际品质的一站式临床研究解决方案，以标准化运营与全流程赋能，构建高质合规、高效透明的研发体系，加速创新转化。公司具备临床早期至上市后全链条服务能力，业务覆盖法规注册事务、医学事务、项目运营管理、统计分析与编程、数据管理、独立评估、药物警戒、患者招募及真实世界洞察。迄今已服务600余家药械企业，开展1600余项临床研究，覆盖肿瘤、心血管、自免、内分泌、肾脏等多个治疗领域。凭借全流程专业实力，助力多项关键临床研究大幅缩短研发周期，推动新药早日获批上市。 公众号二维码: 公司网站:www.taimei.comTaimei CRO is an Al-driven provider of pharmaceutical R&Dsolutions. LeveragingAl as the core driver, we deeply integrateclinical research expertise,Al technol-ogy, and innovative models to offer the industry a moreefficient, transparent, and high-quality intelligent solution. Thiscomprehensive delivery includes:Clinical Operations, Data Science, Medical Science, RegulatoryAffairs, Pharmacovigilance, Patient Recruitment andManagement Platforms, IndependentAssessment & Real-World Insights.We have supported over 600 pharmaceutical and medicaldevice enterprises, delivered more than 1,600 clinical studies,and spanned major therapeutic areassuch as oncology, cardiology, autoimmune, endocrinology,and nephrology. Our end-to-end expertise has drasticallyshortened R&D timelines for critical trials,accelerating the approval and launch of new drugs.